25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Seres Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Seres Therapeutics Inc together

I guess you are interested in Seres Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Seres Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Seres Therapeutics Inc

I send you an email if I find something interesting about Seres Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Seres Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Seres Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-0.32
Expected worth in 1 year
€-1.91
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
€-1.59
Return On Investment
-189.6%

For what price can you sell your share?

Current Price per Share
€0.84
Expected price per share
€0.4971 - €1.0505
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Seres Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
€0.84
Intrinsic Value Per Share
€-5.92 - €-2.17
Total Value Per Share
€-6.24 - €-2.49

2.2. Growth of Seres Therapeutics Inc (5 min.)




Is Seres Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$44.8m$10.7m-$55.6m-124.0%

How much money is Seres Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$119.3m-$262.4m$143.1m120.0%
Net Profit Margin-90.0%-3,509.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Seres Therapeutics Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Seres Therapeutics Inc?

Welcome investor! Seres Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Seres Therapeutics Inc.

First you should know what it really means to hold a share of Seres Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Seres Therapeutics Inc is €0.8408. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Seres Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Seres Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.32. Based on the TTM, the Book Value Change Per Share is €-0.40 per quarter. Based on the YOY, the Book Value Change Per Share is €-1.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Seres Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.88-105.1%-0.88-105.1%-2.10-249.3%-1.18-140.0%-1.40-166.9%
Usd Book Value Change Per Share-0.42-49.7%-0.42-49.7%-1.35-160.0%0.1720.0%-0.06-6.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.42-49.7%-0.42-49.7%-1.35-160.0%0.1720.0%-0.06-6.6%
Usd Price Per Share1.31-1.31-5.38-7.84-7.23-
Price to Earnings Ratio-1.48--1.48--2.57--7.67--6.66-
Price-to-Total Gains Ratio-3.14--3.14--4.00--1.59--1.92-
Price to Book Ratio-3.95--3.95-62.49-13.92-11.01-
Price-to-Total Gains Ratio-3.14--3.14--4.00--1.59--1.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.88225144
Number of shares1133
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.420.17
Usd Total Gains Per Share-0.420.17
Gains per Quarter (1133 shares)-473.90190.68
Gains per Year (1133 shares)-1,895.59762.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1896-19060763753
20-3791-3802015251516
30-5687-5698022882279
40-7582-7594030513042
50-9478-9490038143805
60-11374-11386045764568
70-13269-13282053395331
80-15165-15178061026094
90-17060-17074068646857
100-18956-18970076277620

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%2.04.00.033.3%2.04.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%2.04.00.033.3%2.04.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Seres Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.399-0.3990%-1.282+222%0.160-349%-0.053-87%
Book Value Per Share---0.317-0.3170%0.082-486%0.459-169%0.196-262%
Current Ratio--1.7781.7780%2.275-22%3.143-43%2.986-40%
Debt To Asset Ratio--1.1251.1250%0.969+16%0.916+23%0.996+13%
Debt To Equity Ratio----0%31.346-100%6.801-100%5.668-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---215691734.250-215691734.2500%320024862.944-167%464244072.722-146%387258644.652-156%
Eps---0.842-0.8420%-1.998+137%-1.122+33%-1.338+59%
Ev To Ebitda Ratio--infinfnan%-1.311nan%infnan%infnan%
Ev To Sales Ratio---1.707-1.7070%44.897-104%19.822-109%16.532-110%
Free Cash Flow Per Share---0.884-0.8840%-1.816+105%-0.967+9%-1.058+20%
Free Cash Flow To Equity Per Share---0.378-0.3780%-0.830+119%0.086-541%-0.179-53%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.169--------
Intrinsic Value_10Y_min---5.924--------
Intrinsic Value_1Y_max---0.763--------
Intrinsic Value_1Y_min---0.882--------
Intrinsic Value_3Y_max---1.876--------
Intrinsic Value_3Y_min---2.416--------
Intrinsic Value_5Y_max---2.488--------
Intrinsic Value_5Y_min---3.682--------
Market Cap--168801833.750168801833.7500%642139815.944-74%714647300.522-76%622694117.985-73%
Net Profit Margin---0.900-0.9000%-35.095+3798%-8.351+828%-7.542+738%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.8551.8550%35.581-95%9.237-80%8.456-78%
Pb Ratio-2.656+33%-3.949-3.9490%62.488-106%13.923-128%11.009-136%
Pe Ratio-0.998+33%-1.484-1.4840%-2.567+73%-7.666+416%-6.663+349%
Price Per Share0.841-49%1.2501.2500%5.128-76%7.474-83%6.892-82%
Price To Free Cash Flow Ratio-0.951+33%-1.413-1.4130%-2.824+100%-56.134+3872%-47.218+3241%
Price To Total Gains Ratio-2.109+33%-3.136-3.1360%-4.001+28%-1.593-49%-1.921-39%
Quick Ratio----0%0.214-100%1.082-100%0.902-100%
Return On Assets---0.333-0.3330%-0.753+126%-0.430+29%-0.502+51%
Return On Equity----0%-24.3430%-5.0800%-4.2340%
Total Gains Per Share---0.399-0.3990%-1.282+222%0.160-349%-0.053-87%
Usd Book Value---44855232.962-44855232.9620%10782815.611-516%44771234.399-200%29301998.927-253%
Usd Book Value Change Per Share---0.418-0.4180%-1.345+222%0.168-349%-0.055-87%
Usd Book Value Per Share---0.332-0.3320%0.086-486%0.481-169%0.206-262%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---226325336.749-226325336.7490%335802088.687-167%487131305.507-146%406350495.833-156%
Usd Eps---0.884-0.8840%-2.096+137%-1.177+33%-1.403+59%
Usd Free Cash Flow---125326856.874-125326856.8740%-238632919.307+90%-108769140.016-13%-101439265.359-19%
Usd Free Cash Flow Per Share---0.928-0.9280%-1.906+105%-1.015+9%-1.110+20%
Usd Free Cash Flow To Equity Per Share---0.397-0.3970%-0.871+119%0.090-541%-0.188-53%
Usd Market Cap--177123764.154177123764.1540%673797308.870-74%749879412.438-76%653392938.002-73%
Usd Price Per Share0.882-49%1.3121.3120%5.381-76%7.842-83%7.231-82%
Usd Profit---119330593.200-119330593.2000%-262489740.100+120%-124734068.480+5%-121248363.833+2%
Usd Revenue--132552822.500132552822.5000%7479410.400+1672%71453552.520+86%64488054.283+106%
Usd Total Gains Per Share---0.418-0.4180%-1.345+222%0.168-349%-0.055-87%
 EOD+2 -4MRQTTM+0 -0YOY+20 -145Y+12 -2210Y+12 -22

3.3 Fundamental Score

Let's check the fundamental score of Seres Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.998
Price to Book Ratio (EOD)Between0-1-2.656
Net Profit Margin (MRQ)Greater than0-0.900
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.778
Debt to Asset Ratio (MRQ)Less than11.125
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.333
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Seres Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.800
Ma 20Greater thanMa 500.804
Ma 50Greater thanMa 1000.774
Ma 100Greater thanMa 2000.779
OpenGreater thanClose0.827
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Seres Therapeutics Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Seres Therapeutics Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Seres Therapeutics Inc to the  industry mean.
  • A Net Profit Margin of -90.0% means that €-0.90 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Seres Therapeutics Inc:

  • The MRQ is -90.0%. The company is making a huge loss. -2
  • The TTM is -90.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-90.0%TTM-90.0%0.0%
TTM-90.0%YOY-3,509.5%+3,419.5%
TTM-90.0%5Y-835.1%+745.1%
5Y-835.1%10Y-754.2%-80.8%
4.3.1.2. Return on Assets

Shows how efficient Seres Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Seres Therapeutics Inc to the  industry mean.
  • -33.3% Return on Assets means that Seres Therapeutics Inc generated €-0.33 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Seres Therapeutics Inc:

  • The MRQ is -33.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -33.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.3%TTM-33.3%0.0%
TTM-33.3%YOY-75.3%+42.0%
TTM-33.3%5Y-43.0%+9.8%
5Y-43.0%10Y-50.2%+7.2%
4.3.1.3. Return on Equity

Shows how efficient Seres Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Seres Therapeutics Inc to the  industry mean.
  • 0.0% Return on Equity means Seres Therapeutics Inc generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Seres Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-2,434.3%+2,434.3%
TTM-5Y-508.0%+508.0%
5Y-508.0%10Y-423.4%-84.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Seres Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Seres Therapeutics Inc is operating .

  • Measures how much profit Seres Therapeutics Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Seres Therapeutics Inc to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Seres Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Seres Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.85 means that the operating costs are €1.85 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Seres Therapeutics Inc:

  • The MRQ is 1.855. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.855. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.855TTM1.8550.000
TTM1.855YOY35.581-33.726
TTM1.8555Y9.237-7.382
5Y9.23710Y8.456+0.782
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Seres Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Seres Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.78 means the company has €1.78 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Seres Therapeutics Inc:

  • The MRQ is 1.778. The company is able to pay all its short-term debts. +1
  • The TTM is 1.778. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.778TTM1.7780.000
TTM1.778YOY2.275-0.497
TTM1.7785Y3.143-1.365
5Y3.14310Y2.986+0.156
4.4.3.2. Quick Ratio

Measures if Seres Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Seres Therapeutics Inc to the  industry mean.
  • A Quick Ratio of 0.00 means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Seres Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.214-0.214
TTM-5Y1.082-1.082
5Y1.08210Y0.902+0.180
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Seres Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Seres Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Seres Therapeutics Inc to industry mean.
  • A Debt to Asset Ratio of 1.13 means that Seres Therapeutics Inc assets are financed with 112.5% credit (debt) and the remaining percentage (100% - 112.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Seres Therapeutics Inc:

  • The MRQ is 1.125. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.125. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.125TTM1.1250.000
TTM1.125YOY0.969+0.156
TTM1.1255Y0.916+0.209
5Y0.91610Y0.996-0.081
4.5.4.2. Debt to Equity Ratio

Measures if Seres Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Seres Therapeutics Inc to the  industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Seres Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY31.346-31.346
TTM-5Y6.801-6.801
5Y6.80110Y5.668+1.134
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Seres Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Seres Therapeutics Inc to the  industry mean.
  • A PE ratio of -1.48 means the investor is paying €-1.48 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Seres Therapeutics Inc:

  • The EOD is -0.998. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.484. Based on the earnings, the company is expensive. -2
  • The TTM is -1.484. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.998MRQ-1.484+0.486
MRQ-1.484TTM-1.4840.000
TTM-1.484YOY-2.567+1.083
TTM-1.4845Y-7.666+6.182
5Y-7.66610Y-6.663-1.003
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Seres Therapeutics Inc:

  • The EOD is -0.951. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.413. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.413. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.951MRQ-1.413+0.463
MRQ-1.413TTM-1.4130.000
TTM-1.413YOY-2.824+1.410
TTM-1.4135Y-56.134+54.721
5Y-56.13410Y-47.218-8.916
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Seres Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of -3.95 means the investor is paying €-3.95 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Seres Therapeutics Inc:

  • The EOD is -2.656. Based on the equity, the company is expensive. -2
  • The MRQ is -3.949. Based on the equity, the company is expensive. -2
  • The TTM is -3.949. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.656MRQ-3.949+1.293
MRQ-3.949TTM-3.9490.000
TTM-3.949YOY62.488-66.437
TTM-3.9495Y13.923-17.871
5Y13.92310Y11.009+2.914
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets358,600
Total Liabilities403,456
Total Stockholder Equity-44,856
 As reported
Total Liabilities 403,456
Total Stockholder Equity+ -44,856
Total Assets = 358,600

Assets

Total Assets358,600
Total Current Assets175,410
Long-term Assets183,190
Total Current Assets
Cash And Cash Equivalents 127,965
Inventory 29,647
Other Current Assets 9,124
Total Current Assets  (as reported)175,410
Total Current Assets  (calculated)166,736
+/- 8,674
Long-term Assets
Property Plant Equipment 132,250
Long-term Assets Other 50,940
Long-term Assets  (as reported)183,190
Long-term Assets  (calculated)183,190
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities98,659
Long-term Liabilities304,797
Total Stockholder Equity-44,856
Total Current Liabilities
Accounts payable 3,641
Total Current Liabilities  (as reported)98,659
Total Current Liabilities  (calculated)3,641
+/- 95,018
Long-term Liabilities
Long term Debt 101,544
Capital Lease Obligations Min Short Term Debt112,392
Long-term Liabilities Other 1,628
Long-term Liabilities  (as reported)304,797
Long-term Liabilities  (calculated)215,564
+/- 89,233
Total Stockholder Equity
Total Stockholder Equity (as reported)-44,856
Total Stockholder Equity (calculated)0
+/- 44,856
Other
Capital Stock135
Common Stock Shares Outstanding 135,041
Net Invested Capital 56,688
Net Working Capital 76,751
Property Plant and Equipment Gross 183,388



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
120,472
132,440
342,940
354,859
348,784
358,600
358,600348,784354,859342,940132,440120,472
   > Total Current Assets 
92,665
100,189
268,777
303,628
194,764
175,410
175,410194,764303,628268,777100,18992,665
       Cash And Cash Equivalents 
85,820
65,126
116,049
180,002
163,030
127,965
127,965163,030180,002116,04965,12685,820
       Short-term Investments 
0
29,690
137,567
110,704
18,311
0
018,311110,704137,56729,6900
       Net Receivables 
0
1,785
9,387
0
0
0
0009,3871,7850
       Other Current Assets 
0
3,588
5,774
12,922
13,423
9,124
9,12413,42312,9225,7743,5880
   > Long-term Assets 
27,807
32,251
74,163
51,231
154,020
183,190
183,190154,02051,23174,16332,25127,807
       Property Plant Equipment 
0
30,851
22,938
36,146
133,969
132,250
132,250133,96936,14622,93830,8510
       Long Term Investments 
1,400
0
49,825
495
0
0
0049549,82501,400
       Long-term Assets Other 
1,513
1,400
1,400
14,590
20,051
50,940
50,94020,05114,5901,4001,4001,513
> Total Liabilities 
168,517
180,764
168,190
223,352
338,001
403,456
403,456338,001223,352168,190180,764168,517
   > Total Current Liabilities 
42,041
45,993
46,415
82,258
85,596
98,659
98,65985,59682,25846,41545,99342,041
       Short Long Term Debt 
0
0
454
0
456
0
0456045400
       Accounts payable 
6,415
4,859
4,018
13,735
17,440
3,641
3,64117,44013,7354,0184,8596,415
       Other Current Liabilities 
3,141
670
0
21,098
34,770
0
034,77021,09806703,141
   > Long-term Liabilities 
126,476
134,771
121,775
141,094
252,405
304,797
304,797252,405141,094121,775134,771126,476
       Capital Lease Obligations Min Short Term Debt
7,250
20,132
15,676
24,568
111,543
112,392
112,392111,54324,56815,67620,1327,250
       Long-term Liabilities Other 
7,420
502
1,003
11,495
1,442
1,628
1,6281,44211,4951,0035027,420
> Total Stockholder Equity
-48,045
-48,324
174,750
131,507
10,783
-44,856
-44,85610,783131,507174,750-48,324-48,045
   Common Stock000000
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue126,325
Cost of Revenue--
Gross Profit-126,325
 
Operating Income (+$)
Gross Profit-
Operating Expense-234,308
Operating Income-107,983-234,308
 
Operating Expense (+$)
Research Development145,860
Selling General Administrative87,744
Selling And Marketing Expenses-
Operating Expense234,308233,604
 
Net Interest Income (+$)
Interest Income7,301
Interest Expense-13,176
Other Finance Cost-0
Net Interest Income-5,875
 
Pretax Income (+$)
Operating Income-107,983
Net Interest Income-5,875
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-113,724-108,117
EBIT - interestExpense = -13,176
-113,724
-100,548
Interest Expense13,176
Earnings Before Interest and Taxes (EBIT)--100,548
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-113,724
Tax Provision--
Net Income From Continuing Ops-113,724-113,724
Net Income-113,724
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1345,875
 

Technical Analysis of Seres Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Seres Therapeutics Inc. The general trend of Seres Therapeutics Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Seres Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Seres Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.9256 < 1.013 < 1.0505.

The bearish price targets are: 0.5174 > 0.4971.

Tweet this
Seres Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Seres Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Seres Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Seres Therapeutics Inc. The current macd is -0.00099006.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Seres Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Seres Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Seres Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Seres Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartSeres Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Seres Therapeutics Inc. The current adx is 20.39.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Seres Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Seres Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Seres Therapeutics Inc. The current sar is 0.6882.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Seres Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Seres Therapeutics Inc. The current rsi is 54.80. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Seres Therapeutics Inc Daily Relative Strength Index (RSI) ChartSeres Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Seres Therapeutics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Seres Therapeutics Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Seres Therapeutics Inc Daily Stochastic Oscillator ChartSeres Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Seres Therapeutics Inc. The current cci is 40.08.

Seres Therapeutics Inc Daily Commodity Channel Index (CCI) ChartSeres Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Seres Therapeutics Inc. The current cmo is 14.43.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Seres Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartSeres Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Seres Therapeutics Inc. The current willr is -22.85136502.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Seres Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Seres Therapeutics Inc Daily Williams %R ChartSeres Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Seres Therapeutics Inc.

Seres Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Seres Therapeutics Inc. The current atr is 0.04446535.

Seres Therapeutics Inc Daily Average True Range (ATR) ChartSeres Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Seres Therapeutics Inc. The current obv is 16,918.

Seres Therapeutics Inc Daily On-Balance Volume (OBV) ChartSeres Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Seres Therapeutics Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Seres Therapeutics Inc Daily Money Flow Index (MFI) ChartSeres Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Seres Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Seres Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Seres Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.800
Ma 20Greater thanMa 500.804
Ma 50Greater thanMa 1000.774
Ma 100Greater thanMa 2000.779
OpenGreater thanClose0.827
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Seres Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Seres Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Seres Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Seres Therapeutics Inc

I send you an email if I find something interesting about Seres Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Seres Therapeutics Inc.

Receive notifications about Seres Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.